Advanced Therapies other research news

The Novato, Calif., company received a $172,000 grant from the Cystic Fibrosis Foundation to develop gene therapy products delivered via aerosol using its artificial viral envelope (AVE) technology.

The grant was awarded to Hans Schreier at the Center for Lung Research, Vanderbuilt University School of Medicine. Schreier, a co-founder of Advanced Therapies, requested the grant be transferred to the company. ...